1. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors;Dagher;Clin. Cancer Res.,2002
2. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia;Cohen;Clin. Cancer Res.,2002
3. Current therapy of chronic myelogenous leukemia;Garcia-Manero;Intern. Med.,2002
4. Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase;Schindler;Science,2000
5. Abl protein–tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors;Buchdunger;J. Pharmacol. Exp. Ther.,2000